Search
for
Sort by
Research 241–270 of 1000+
- Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women?
- Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
- Correlation between Hormonal Imbalances and Adult Female Acne
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- EFFECT OF THYROID DYSFUNCTION ON BODY MASS INDEX AND HORMONAL IMBALANCE IN WOMEN HAVING POLYCYSTIC OVARIAN SYNDROME
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Study of cutaneous manifestations of polycystic ovarian syndrome
- Cutaneous Side Effects of Oral Contraceptives
- Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris
- Synergistic Effects of Cinnamomum zeylanicum and Inositol on Metabolic and Hormonal Parameters in Women with Polycystic Ovary Syndrome
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Correlations between hormonal intrauterine devices and androgenic skin conditions: A retrospective cohort study
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- A clinico-pathological study of Neogynon as a new oral contraceptive steroid.
- CLINICAL UPDATES IN HAIR
- The Hirsute Woman: Challenges in Evaluation and Management
- Melasma and other skin manifestations or oral contraceptives.
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Complications of Subcutaneous Contraception: A Review
- Assessment, diagnosis and treatment of a patient with hirsutism
- Menopausal Acne – Challenges And Solutions
- Ethinylestradiol/Chlormadinone Acetate
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Management OF Patients with Polycystic Ovary Syndrom